The pet prescription gap: what your customers are quietly paying every month

Many of the drugs a vet dispenses in-clinic are the same molecules — often the same manufacturer, the same NDC — as drugs sold at every human pharmacy in the country. And they are almost never priced the same. That gap is the story of a whole product category most Shopify stores in the pet space aren't doing anything about at checkout — and it's a category their customers are already paying into every month.

The scale of the problem

The pet economy is not a rounding error anymore. The American Pet Products Association put U.S. pet spending at $158 billion in 2025, with veterinary care and product sales at roughly $41 billion of that. Prescription drugs are a rising share of the vet line, because chronic conditions — diabetes, hypothyroidism, heart disease, arthritis, epilepsy — are more common as pets live longer, and those conditions get treated with month-after-month refills rather than a single visit and a cure.

That is the shape of the problem for retailers: a growing number of customers are not paying a one-time vet bill and moving on. They are paying every four weeks for the rest of the animal's life. And most of them do not know they have any option other than the clinic counter.

Same molecule, different shelf

Insulin (glargine, NPH), levothyroxine, gabapentin, tramadol, prednisone, furosemide, enalapril, amoxicillin, fluoxetine, and dozens of others are filled routinely for pets and are also sitting on the shelf at CVS, Walmart, Walgreens, Kroger, and Safeway. The FDA does not maintain a separate "pet" version of most of these drugs — they are the same product on the same production line, just filled against a script that names a dog or a cat instead of a person.

Clinics tend to mark up in-house dispensing three to seven times a retail pharmacy's cash price. There are structural reasons for it — small carrying costs, low inventory turnover, staff time, no PBM leverage — but the end result is that a 30-day supply of a common thyroid drug that runs a few dollars at Walmart is often $30 to $60 at the clinic. Owners rarely comparison-shop between the vet counter and the pharmacy across the parking lot, mostly because they don't know they can. Vets will write a paper or e-scripted prescription for a human-labeled generic if asked, but most owners don't think to ask.

What a discount card actually is

A pet prescription savings card is not insurance. It's a group-purchasing arrangement. The card operator negotiates a discounted cash price with a pharmacy benefit manager, and the pharmacy honors that price at the register in exchange for the volume the network brings. The customer hands over a card, a screenshot, or a code at the pharmacy counter; the tech runs the BIN and PCN through the same rails they use for human plans; the price drops. No claim to file, no deductible, no monthly premium. If the discounted price happens to be worse than the pharmacy's own cash price, the pharmacy uses the cash price. There is no way for the customer to lose money by presenting the card.

Savings on eligible drugs typically run up to 70 percent, depending on the molecule and the pharmacy. That number matters most on the chronic scripts where the owner is paying every single month for years.

For a Shopify store, a card is unusually low-friction to add. There is no underwriting, no premium collection, no state-by-state filing regime. The store is not a party to the transaction between the shopper and the pharmacy — it is just the introducer. Install the app, and the offer shows up in the order confirmation or thank-you page. That is the whole integration.

The insurance bridge

For owners who look at that receipt and start to think about the next surgery or the next diagnostic, the natural follow-on question is coverage. Pet insurance in North America is still an early market. NAPHIA's 2026 State of the Industry Report put the segment at $5.7 billion in gross written premium in 2025, with only 4.27 percent of U.S. pets insured. That penetration rate trails Sweden and the UK by an order of magnitude.

The card is a good on-ramp to the insurance conversation because the two products speak to related problems. A card handles the predictable monthly cost. Insurance handles the tail risk. Owners who have been surprised once by a $6,000 orthopedic bill tend to be receptive; owners who have never been surprised are harder to reach cold. A prescription-savings moment — the receipt, the pharmacy visit, the realization of what these drugs actually cost over a year — is a plausible trigger for the insurance question to make sense a few weeks later.

What retailers should look for

If a pet-industry Shopify store is going to add a savings card as a checkout benefit, a handful of things matter more than the marketing:

• Pharmacy network breadth. The card is worthless if the shopper's local pharmacy doesn't take it. Coverage should include CVS, Walmart, Walgreens, Kroger, and Safeway — the five chains that cover the majority of U.S. zip codes.
• Zero cost to the customer, always. No trial, no upgrade to a paid tier, no upsell at the pharmacy counter. If the customer can be charged, the offer is not what the store thinks it is.
• Zero cost to the store to install. A free app should actually be free. Watch for setups that require a paid plan for the useful tier.
• Where the downstream revenue comes from. In a well-structured program, the card operator earns a small transaction fee from the PBM on each fill, and the store shares in it. That's how a benefit that costs the customer nothing can still be worth installing.

That last point is why "free to customer" is not the same as "no economics." Card usage generates a per-fill fee that flows back through the network. It is not enormous per script, but a store with tens of thousands of pet owners and a category of chronic-med users compounds it quickly.

The discount-card model has been running in the human pharmacy world for well over a decade — the mechanics are well-understood, the PBM plumbing exists, and consumers who use one for their own scripts already know how it works at the counter. Applying the same model to a $41 billion pet-care market that is still buying most of its meds retail-priced from the clinic is not clever; it is overdue. PetRx by Flex is one way to add it; the read on the category is the same regardless of which partner a store picks.